Protalix BioTherapeutics
PLX
#6636
Rank
$60.54 M
Marketcap
$1.20
Share price
5.75%
Change (1 day)
48.15%
Change (1 year)

Market capitalization of Protalix BioTherapeutics (PLX)

Market cap: $60.54 Million

As of December 2022 Protalix BioTherapeutics has a market cap of $60.54 Million. This makes Protalix BioTherapeutics the world's 6636th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Protalix BioTherapeutics from 2001 to 2022

End of year Market Cap

Year Market cap Change
2022$60.54 M59.79%
2021$37.88 M-68.69%
2020$0.12 B148.64%
2019$48.66 M5.47%
2018$46.14 M-50.05%
2017$92.38 M67.73%
2016$55.08 M-45.89%
2015$0.10 B-40.9%
2014$0.17 B-52.64%
2013$0.36 B-25.05%
2012$0.48 B14.95%
2011$0.42 B-47.68%
2010$0.80 B50.76%
2009$0.53 B283.05%
2008$0.13 B-45.77%
2007$0.25 B-75.03%
2006$1.03 B4063.51%
2005$24.78 M4150%
2004$0.58 M-50%
2003$1.16 M263.64%
2002$0.32 M-52.17%
2001$0.67 M

End of Day market cap according to different sources

On Dec 4th, 2022 the market cap of Protalix BioTherapeutics was reported to be:

$57.25 Million
by Nasdaq
$57.25 Million
by CompaniesMarketCap
$56.22 Million
by Iex Cloud

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
$283.89 B 468,793.08%๐Ÿ‡บ๐Ÿ‡ธ USA
$11.98 B 19,701.54%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.46 B 5,623.73%๐Ÿ‡บ๐Ÿ‡ธ USA
$9.56 B 15,703.29%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel